Abstract:Abstract Background: Fenofibrate (FF) is a BCS class II compound whose poor solubility poses challenges in drug delivery and bioavailability. Solid self-micro emulsifying drug delivery systems (S-SMEDDS) have emerged as a promising solution to address these issues. These systems are aimed at enhancing the solubility and dissolution rates of poorly soluble drugs, such as FF, by formulating them into solid dosage forms. Methods: FF solubility was investigated in various oils, surfactants, and co-surfactants to identify the most suitable components for formulating S-SMEDDS. The preparation of S-SMEDDS was carefully evaluated according to parameters including drug content, morphological characteristics, and structural features. Two methods, freeze-drying, and spray-drying, were compared for their efficacy in producing S-SMEDDS. Additionally, in vitro dissolution studies were conducted to assess the dissolution rates of FF-loaded S-SMEDDS tablets compared with conventional tablets. Results: Among the oils tested, oleic oil achieved the highest FF solubility, whereas Tween 80 and Transcutol HP were identified as the optimal surfactant and co-surfactant, respectively. The preparation method significantly influenced the properties of S-SMEDDS. Freeze-drying outperformed the other methods by enhancing dissolution rates, primarily through increased surface area. Moreover, the solid-state characteristics of S-SMEDDS were dependent on the polymer concentration and processing method. In vitro dissolution studies demonstrated that FF-loaded S-SMEDDS tablets exhibited faster drug release than conventional tablets, owing to the inclusion of the super disintegrating agent CCS and the S-SMEDDS component. Freeze-drying was superior to spray-drying in enhancing dissolution, albeit with potentially higher production costs. Conclusions: The study highlights the potential of S-SMEDDS to overcome the solubility and bioavailability challenges associated with FF. Freeze-drying emerged as the preferred method for producing S-SMEDDS, because of its superior dissolution enhancement capabilities, despite potentially higher production costs, whereas spray-dried S-SMEDDS offers economic and environmental benefits, but may achieve lower dissolution rates. Overall, our findings underscore the importance of formulation strategy in enhancing the efficacy of poorly soluble drugs such as FF.

The potential of sonocrystallization in crystal habit modification for improving micromeritic and physicochemical properties of Dapagliflozin

Dapagliflozin-citric Acid Cocrystal Showing Better Solid State Properties Than Dapagliflozin

Impact of Crystal Habit on Solubility of Ticagrelor

Optimizing irbesartan spherical agglomerates through principal component analysis and experimental design

Process development in Quality‐by‐Design paradigm for anti‐solvent aided crystallization: impact of crystallization parameters on particle morphology and dissolution behaviour of Dexlansoprazole active pharmaceutical ingredient

Fabrication of prostructured spanlastics gel for improving transdermal effect of dapagliflozin: In vitro characterization studies and in vivo antidiabetic activity

Study of Hot Melt Granulation to Improve Dissolution Rate of Empagliflozin

Role of Porous Carriers in the Biopharmaceutical Performance of Solid SMEDDS of Canagliflozin

Increasing the Dissolution Rate of A Low-Solubility Drug Through A Crystalline-Amorphous Transition: A Case Study with Indomethicin

Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches

Comparative Study of Spray-Drying and Freeze-Drying Techniques for Increasing Fenofibrate’s Solubility and Dissolution Rate

Transforming canagliflozin solubility using lipidic carrier and its pharmacokinetic study

Solubility Enhancement of Antidiabetic Drugs Using a Co‐Crystallization Approach

Ultrasound-assisted solution crystallization of fotagliptin benzoate: Process intensification and crystal product optimization

Tuning Physicochemical Properties of Antipsychotic Drug Aripiprazole with Multicomponent Crystal Strategy Based on Structure and Property Relationship

A Mixed Solvent System for Preparation of Spherically Agglomerated Crystals of Ascorbic Acid.

Solid-State Characterization of Different Crystalline Forms of Sitagliptin

Co-Crystallization: A Novel Technique to Improvise the Pharmaceutical Characteristics of API's

Quantifying solubility enhancement due to particle size reduction and crystal habit modification: case study of acetyl salicylic acid

Fabrication and Characterization of Gliclazide Nanocrystals

Simultaneously Improving the Physicochemical Properties, Dissolution Performance and Bioavailability of Apigenin and Daidzein by Co-crystallization with Theophylline.